 | • レポートコード：MRC2102QY11696 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のヒト用予防ワクチン市場について種類別（不活化ワクチン、弱毒化ワクチン、その他）、用途別（病院、科学研究、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ヒト用予防ワクチン市場の概要 ・世界の主要地域別ヒト用予防ワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のヒト用予防ワクチン市場規模2015-2026：種類別（不活化ワクチン、弱毒化ワクチン、その他） ・世界のヒト用予防ワクチン市場規模2015-2026：用途別（病院、科学研究、その他） ・ヒト用予防ワクチンの米国市場規模2015-2020 ・ヒト用予防ワクチンのヨーロッパ市場規模2015-2020 ・ヒト用予防ワクチンの中国市場規模2015-2020 ・ヒト用予防ワクチンの日本市場規模2015-2020 ・ヒト用予防ワクチンの東南アジア市場規模2015-2020 ・ヒト用予防ワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・ヒト用予防ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ヒト用予防ワクチンの市場動向・機会・課題 ・調査の結論 |
Vaccination in the body of a healthy person causes the person to produce antibodies and obtain specific immunity in the absence of disease. For example, BCG vaccination, smallpox vaccination and so on.
Market Analysis and Insights: Global Prophylactic Human Vaccine Market
The global Prophylactic Human Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Prophylactic Human Vaccine Scope and Market Size
The global Prophylactic Human Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Prophylactic Human Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Prophylactic Human Vaccine market is segmented into
Inactivated Vaccine
Attenuated Vaccine
Others
Segment by Application, the Prophylactic Human Vaccine market is segmented into
Hospital
Scientific Research
Others
The Prophylactic Human Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Prophylactic Human Vaccine market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Prophylactic Human Vaccine Market Share Analysis
Prophylactic Human Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Prophylactic Human Vaccine business, the date to enter into the Prophylactic Human Vaccine market, Prophylactic Human Vaccine product introduction, recent developments, etc.
The major vendors covered:
GSK
Biovac
McKesson Medical
Merck
Merial
Zoetis
Sanofi
1 Prophylactic Human Vaccine Market Overview
1.1 Prophylactic Human Vaccine Product Scope
1.2 Prophylactic Human Vaccine Segment by Type
1.2.1 Global Prophylactic Human Vaccine Sales by Type (2020-2026)
1.2.2 Inactivated Vaccine
1.2.3 Attenuated Vaccine
1.2.4 Others
1.3 Prophylactic Human Vaccine Segment by Application
1.3.1 Global Prophylactic Human Vaccine Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Scientific Research
1.3.4 Others
1.4 Prophylactic Human Vaccine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Prophylactic Human Vaccine Sales Growth Rate (2015-2026)
1.4.2 Global Prophylactic Human Vaccine Revenue and Growth Rate (2015-2026)
1.4.3 Global Prophylactic Human Vaccine Price Trends (2015-2026)
2 Prophylactic Human Vaccine Estimate and Forecast by Region
2.1 Global Prophylactic Human Vaccine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Prophylactic Human Vaccine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Prophylactic Human Vaccine Sales Market Share by Region (2015-2020)
2.2.2 Global Prophylactic Human Vaccine Revenue Market Share by Region (2015-2020)
2.3 Global Prophylactic Human Vaccine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Prophylactic Human Vaccine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Prophylactic Human Vaccine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Prophylactic Human Vaccine Estimates and Projections (2015-2026)
2.4.2 Europe Prophylactic Human Vaccine Estimates and Projections (2015-2026)
2.4.3 China Prophylactic Human Vaccine Estimates and Projections (2015-2026)
2.4.4 Japan Prophylactic Human Vaccine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Prophylactic Human Vaccine Estimates and Projections (2015-2026)
2.4.6 India Prophylactic Human Vaccine Estimates and Projections (2015-2026)
3 Global Prophylactic Human Vaccine Competition Landscape by Players
3.1 Global Top Prophylactic Human Vaccine Players by Sales (2015-2020)
3.2 Global Top Prophylactic Human Vaccine Players by Revenue (2015-2020)
3.3 Global Prophylactic Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prophylactic Human Vaccine as of 2019)
3.4 Global Prophylactic Human Vaccine Average Price by Company (2015-2020)
3.5 Manufacturers Prophylactic Human Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Prophylactic Human Vaccine Players (Opinion Leaders)
4 Global Prophylactic Human Vaccine Market Size by Type
4.1 Global Prophylactic Human Vaccine Historic Market Review by Type (2015-2020)
4.1.1 Global Prophylactic Human Vaccine Sales Market Share by Type (2015-2020)
4.1.2 Global Prophylactic Human Vaccine Revenue Market Share by Type (2015-2020)
4.1.3 Global Prophylactic Human Vaccine Price by Type (2015-2020)
4.2 Global Prophylactic Human Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Prophylactic Human Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Prophylactic Human Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Global Prophylactic Human Vaccine Price Forecast by Type (2021-2026)
5 Global Prophylactic Human Vaccine Market Size by Application
5.1 Global Prophylactic Human Vaccine Historic Market Review by Application (2015-2020)
5.1.1 Global Prophylactic Human Vaccine Sales Market Share by Application (2015-2020)
5.1.2 Global Prophylactic Human Vaccine Revenue Market Share by Application (2015-2020)
5.1.3 Global Prophylactic Human Vaccine Price by Application (2015-2020)
5.2 Global Prophylactic Human Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Prophylactic Human Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Prophylactic Human Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Prophylactic Human Vaccine Price Forecast by Application (2021-2026)
6 United States Prophylactic Human Vaccine Market Facts & Figures
6.1 United States Prophylactic Human Vaccine Sales Market Share by Company (2015-2020)
6.2 United States Prophylactic Human Vaccine Sales Market Share by Type (2015-2020)
6.3 United States Prophylactic Human Vaccine Sales Market Share by Application (2015-2020)
7 Europe Prophylactic Human Vaccine Market Facts & Figures
7.1 Europe Prophylactic Human Vaccine Sales Market Share by Company (2015-2020)
7.2 Europe Prophylactic Human Vaccine Sales Market Share by Type (2015-2020)
7.3 Europe Prophylactic Human Vaccine Sales Market Share by Application (2015-2020)
8 China Prophylactic Human Vaccine Market Facts & Figures
8.1 China Prophylactic Human Vaccine Sales Market Share by Company (2015-2020)
8.2 China Prophylactic Human Vaccine Sales Market Share by Type (2015-2020)
8.3 China Prophylactic Human Vaccine Sales Market Share by Application (2015-2020)
9 Japan Prophylactic Human Vaccine Market Facts & Figures
9.1 Japan Prophylactic Human Vaccine Sales Market Share by Company (3015-3030)
9.2 Japan Prophylactic Human Vaccine Sales Market Share by Type (2015-2020)
9.3 Japan Prophylactic Human Vaccine Sales Market Share by Application (2015-2020)
10 Southeast Asia Prophylactic Human Vaccine Market Facts & Figures
10.1 Southeast Asia Prophylactic Human Vaccine Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Prophylactic Human Vaccine Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Prophylactic Human Vaccine Sales Market Share by Application (2015-2020)
11 India Prophylactic Human Vaccine Market Facts & Figures
11.1 India Prophylactic Human Vaccine Sales Market Share by Company (2015-2020)
11.2 India Prophylactic Human Vaccine Sales Market Share by Type (2015-2020)
11.3 India Prophylactic Human Vaccine Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Prophylactic Human Vaccine Business
12.1 GSK
12.1.1 GSK Corporation Information
12.1.2 GSK Business Overview
12.1.3 GSK Prophylactic Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 GSK Prophylactic Human Vaccine Products Offered
12.1.5 GSK Recent Development
12.2 Biovac
12.2.1 Biovac Corporation Information
12.2.2 Biovac Business Overview
12.2.3 Biovac Prophylactic Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Biovac Prophylactic Human Vaccine Products Offered
12.2.5 Biovac Recent Development
12.3 McKesson Medical
12.3.1 McKesson Medical Corporation Information
12.3.2 McKesson Medical Business Overview
12.3.3 McKesson Medical Prophylactic Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 McKesson Medical Prophylactic Human Vaccine Products Offered
12.3.5 McKesson Medical Recent Development
12.4 Merck
12.4.1 Merck Corporation Information
12.4.2 Merck Business Overview
12.4.3 Merck Prophylactic Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Merck Prophylactic Human Vaccine Products Offered
12.4.5 Merck Recent Development
12.5 Merial
12.5.1 Merial Corporation Information
12.5.2 Merial Business Overview
12.5.3 Merial Prophylactic Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Merial Prophylactic Human Vaccine Products Offered
12.5.5 Merial Recent Development
12.6 Zoetis
12.6.1 Zoetis Corporation Information
12.6.2 Zoetis Business Overview
12.6.3 Zoetis Prophylactic Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Zoetis Prophylactic Human Vaccine Products Offered
12.6.5 Zoetis Recent Development
12.7 Sanofi
12.7.1 Sanofi Corporation Information
12.7.2 Sanofi Business Overview
12.7.3 Sanofi Prophylactic Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Sanofi Prophylactic Human Vaccine Products Offered
12.7.5 Sanofi Recent Development
…
13 Prophylactic Human Vaccine Manufacturing Cost Analysis
13.1 Prophylactic Human Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Prophylactic Human Vaccine
13.4 Prophylactic Human Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Prophylactic Human Vaccine Distributors List
14.3 Prophylactic Human Vaccine Customers
15 Market Dynamics
15.1 Prophylactic Human Vaccine Market Trends
15.2 Prophylactic Human Vaccine Opportunities and Drivers
15.3 Prophylactic Human Vaccine Market Challenges
15.4 Prophylactic Human Vaccine Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Prophylactic Human Vaccine Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Prophylactic Human Vaccine Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Prophylactic Human Vaccine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Prophylactic Human Vaccine Sales (K Units) by Region (2015-2020)
Table 5. Global Prophylactic Human Vaccine Sales Market Share by Region (2015-2020)
Table 6. Global Prophylactic Human Vaccine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Prophylactic Human Vaccine Revenue Share by Region (2015-2020)
Table 8. Global Prophylactic Human Vaccine Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Prophylactic Human Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Prophylactic Human Vaccine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Prophylactic Human Vaccine Revenue Share Forecast by Region (2021-2026)
Table 12. Global Prophylactic Human Vaccine (K Units) of Key Companies (2015-2020)
Table 13. Global Prophylactic Human Vaccine Sales Share by Company (2015-2020)
Table 14. Global Prophylactic Human Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Prophylactic Human Vaccine Revenue Share by Company (2015-2020)
Table 16. Global Prophylactic Human Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prophylactic Human Vaccine as of 2019)
Table 17. Global Prophylactic Human Vaccine Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Prophylactic Human Vaccine Manufacturing Sites and Area Served
Table 19. Manufacturers Prophylactic Human Vaccine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Prophylactic Human Vaccine Players
Table 22. Global Prophylactic Human Vaccine Sales (K Units) by Type (2015-2020)
Table 23. Global Prophylactic Human Vaccine Sales Share by Type (2015-2020)
Table 24. Global Prophylactic Human Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Prophylactic Human Vaccine Price (K Units) by Type (2015-2020)
Table 26. Global Prophylactic Human Vaccine Sales Share by Type (2021-2026)
Table 27. Global Prophylactic Human Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Prophylactic Human Vaccine Revenue Share by Type (2021-2026)
Table 29. Global Prophylactic Human Vaccine Price (K Units) by Type (2021-2026)
Table 30. Global Prophylactic Human Vaccine Sales (K Units) by Application (2015-2020)
Table 31. Global Prophylactic Human Vaccine Sales Share by Application (2015-2020)
Table 32. Global Prophylactic Human Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Prophylactic Human Vaccine Price (K Units) by Application (2015-2020)
Table 34. Global Prophylactic Human Vaccine Sales (K Units) by Application (2021-2026)
Table 35. Global Prophylactic Human Vaccine Sales Share by Application (2021-2026)
Table 36. Global Prophylactic Human Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Prophylactic Human Vaccine Revenue Share by Application (2021-2026)
Table 38. Global Prophylactic Human Vaccine Price (K Units) by Application (2021-2026)
Table 39. United States Prophylactic Human Vaccine Sales (K Units) by Company (2015-2020)
Table 40. United States Prophylactic Human Vaccine Sales Market Share by Company (2015-2020)
Table 41. United States Prophylactic Human Vaccine Sales (K Units) by Type (2015-2020)
Table 42. United States Prophylactic Human Vaccine Sales Market Share by Type (2015-2020)
Table 43. United States Prophylactic Human Vaccine Sales (K Units) by Application (2015-2020)
Table 44. United States Prophylactic Human Vaccine Sales Market Share by Application (2015-2020)
Table 45. Europe Prophylactic Human Vaccine Sales (K Units) by Company (2015-2020)
Table 46. Europe Prophylactic Human Vaccine Sales Market Share by Company (2015-2020)
Table 47. Europe Prophylactic Human Vaccine Sales (K Units) by Type (2015-2020)
Table 48. Europe Prophylactic Human Vaccine Sales Market Share by Type (2015-2020)
Table 49. Europe Prophylactic Human Vaccine Sales (K Units) by Application (2015-2020)
Table 50. Europe Prophylactic Human Vaccine Sales Market Share by Type (2015-2020)
Table 51. China Prophylactic Human Vaccine Sales (K Units) by Company (2015-2020)
Table 52. China Prophylactic Human Vaccine Sales Market Share by Company (2015-2020)
Table 53. China Prophylactic Human Vaccine Sales (K Units) by Type (2015-2020)
Table 54. China Prophylactic Human Vaccine Sales Market Share by Type (2015-2020)
Table 55. China Prophylactic Human Vaccine Sales (K Units) by Application (2015-2020)
Table 56. China Prophylactic Human Vaccine Sales Market Share by Application (2015-2020)
Table 57. Japan Prophylactic Human Vaccine Sales (K Units) by Company (2015-2020)
Table 58. Japan Prophylactic Human Vaccine Sales Market Share by Company (2015-2020)
Table 59. Japan Prophylactic Human Vaccine Sales (K Units) by Type (2015-2020)
Table 60. Japan Prophylactic Human Vaccine Sales Market Share by Type (2015-2020)
Table 61. Japan Prophylactic Human Vaccine Sales (K Units) by Application (2015-2020)
Table 62. Japan Prophylactic Human Vaccine Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Prophylactic Human Vaccine Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Prophylactic Human Vaccine Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Prophylactic Human Vaccine Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Prophylactic Human Vaccine Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Prophylactic Human Vaccine Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Prophylactic Human Vaccine Sales Market Share by Application (2015-2020)
Table 69. India Prophylactic Human Vaccine Sales (K Units) by Company (2015-2020)
Table 70. India Prophylactic Human Vaccine Sales Market Share by Company (2015-2020)
Table 71. India Prophylactic Human Vaccine Sales (K Units) by Type (2015-2020)
Table 72. India Prophylactic Human Vaccine Sales Market Share by Type (2015-2020)
Table 73. India Prophylactic Human Vaccine Sales (K Units) by Application (2015-2020)
Table 74. India Prophylactic Human Vaccine Sales Market Share by Application (2015-2020)
Table 75. GSK Corporation Information
Table 76. GSK Description and Business Overview
Table 77. GSK Prophylactic Human Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. GSK Prophylactic Human Vaccine Product
Table 79. GSK Recent Development
Table 80. Biovac Corporation Information
Table 81. Biovac Description and Business Overview
Table 82. Biovac Prophylactic Human Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Biovac Prophylactic Human Vaccine Product
Table 84. Biovac Recent Development
Table 85. McKesson Medical Corporation Information
Table 86. McKesson Medical Description and Business Overview
Table 87. McKesson Medical Prophylactic Human Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. McKesson Medical Prophylactic Human Vaccine Product
Table 89. McKesson Medical Recent Development
Table 90. Merck Corporation Information
Table 91. Merck Description and Business Overview
Table 92. Merck Prophylactic Human Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Merck Prophylactic Human Vaccine Product
Table 94. Merck Recent Development
Table 95. Merial Corporation Information
Table 96. Merial Description and Business Overview
Table 97. Merial Prophylactic Human Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Merial Prophylactic Human Vaccine Product
Table 99. Merial Recent Development
Table 100. Zoetis Corporation Information
Table 101. Zoetis Description and Business Overview
Table 102. Zoetis Prophylactic Human Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Zoetis Prophylactic Human Vaccine Product
Table 104. Zoetis Recent Development
Table 105. Sanofi Corporation Information
Table 106. Sanofi Description and Business Overview
Table 107. Sanofi Prophylactic Human Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Sanofi Prophylactic Human Vaccine Product
Table 109. Sanofi Recent Development
Table 110. Production Base and Market Concentration Rate of Raw Material
Table 111. Key Suppliers of Raw Materials
Table 112. Prophylactic Human Vaccine Distributors List
Table 113. Prophylactic Human Vaccine Customers List
Table 114. Prophylactic Human Vaccine Market Key Trends
Table 115. Prophylactic Human Vaccine Key Opportunities and Drivers
Table 116. Prophylactic Human Vaccine Market Challenges
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Prophylactic Human Vaccine Product Picture
Figure 2. Global Prophylactic Human Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Prophylactic Human Vaccine Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Scientific Research Examples
Figure 8. Others Examples
Figure 9. Global Prophylactic Human Vaccine Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Prophylactic Human Vaccine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Prophylactic Human Vaccine Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Prophylactic Human Vaccine Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Prophylactic Human Vaccine Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Prophylactic Human Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Prophylactic Human Vaccine Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Prophylactic Human Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Prophylactic Human Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Prophylactic Human Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Prophylactic Human Vaccine Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Prophylactic Human Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Prophylactic Human Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Prophylactic Human Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Prophylactic Human Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Prophylactic Human Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Prophylactic Human Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Prophylactic Human Vaccine Players Market Share by Revenue in Prophylactic Human Vaccine 2015 & 2019
Figure 27. Prophylactic Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Prophylactic Human Vaccine Revenue Share by Type (2015-2020)
Figure 29. Global Prophylactic Human Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Prophylactic Human Vaccine Revenue Share by Application (2015-2020)
Figure 31. Global Prophylactic Human Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Prophylactic Human Vaccine Sales Market Share by Type in 2019
Figure 33. United States Prophylactic Human Vaccine Sales Market Share by Type in 2019
Figure 34. Europe Prophylactic Human Vaccine Sales Market Share by Company in 2019
Figure 35. Europe Prophylactic Human Vaccine Sales Market Share by Type in 2019
Figure 36. Europe Prophylactic Human Vaccine Sales Market Share by Application in 2019
Figure 37. China Prophylactic Human Vaccine Sales Market Share by Company in 2019
Figure 38. China Prophylactic Human Vaccine Sales Market Share by Type in 2019
Figure 39. China Prophylactic Human Vaccine Sales Market Share by Application in 2019
Figure 40. Japan Prophylactic Human Vaccine Sales Market Share by Company in 2019
Figure 41. Japan Prophylactic Human Vaccine Sales Market Share by Type in 2019
Figure 42. Japan Prophylactic Human Vaccine Sales Market Share by Application in 2019
Figure 43. Southeast Asia Prophylactic Human Vaccine Sales Market Share by Company in 2019
Figure 44. Southeast Asia Prophylactic Human Vaccine Sales Market Share by Type in 2019
Figure 45. Southeast Asia Prophylactic Human Vaccine Sales Market Share by Application in 2019
Figure 46. India Prophylactic Human Vaccine Sales Market Share by Company in 2019
Figure 47. India Prophylactic Human Vaccine Sales Market Share by Type in 2019
Figure 48. India Prophylactic Human Vaccine Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Prophylactic Human Vaccine
Figure 51. Manufacturing Process Analysis of Prophylactic Human Vaccine
Figure 52. Prophylactic Human Vaccine Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
ヒト用ワクチンの世界市場レポート2020 A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. China …- ヒトサイトメガロウイルスエンベロープ糖タンパク質Bの世界市場レポート2020 Market Analysis and Insights: Global Human Cytomegalovirus Envelope Glycoprotein B Market The global Human Cytomegalovirus Envelope Glycoprotein B market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Human Cytomegalovirus En…
- 麻疹（はしか）ワクチンの世界市場レポート2020 Measles vaccine is made by inoculation of attenuated strain of measles virus into chicken embryo cells, culture and harvesting of virus venom, and then freeze-drying. Injection into the lateral deltoid muscle attachment of the upper arm can prevent measles. Market Analysis and Insights: Global Measl…
- 弱毒生水痘ワクチンの世界市場レポート2020 A live attenuated varicella vaccine, derived from the Oka strain of VZV has clinical efficacy for the prevention of varicella. The downstream industries of varicella attenuated live vaccine products are kids and adults. In the recent years, with the recovery of global economic, the development of em…
- 不活化ワクチンの世界市場レポート2020 Inactivated vaccines are viruses or bacteria that are first cultured and then inactivated with heat or chemicals. Inactivated vaccines may consist of whole viruses or bacteria, or they may consist of fragments that cleave together to form a cleaved vaccine. Market Analysis and Insights: Global Inact…